X

Dr. Lal Pathlabs Ltd. Stock Analysis

Mid Cap
Evaluated by 1430 users | BSE: 539524 | NSE: LALPATHLAB |
Hospital & Healthcare Services
1. Right Stock
Very Good
2. Right Price
3. Right Time

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dr. Lal Pathlabs Ltd. has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation
Value Creation Index Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 27.78%38.47%37.39%40.82%34.42%31.57%28.76%24.68%22.66%23.4%
Value Creation Index 1.322.212.122.401.871.631.401.060.890.95
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 2253194215416377658821,0241,1651,274
Y-o-Y Gr. Rt.-42.1%32%28.4%17.7%20.2%15.2%16.1%13.8%9.3%
Adjusted EPS (Rs.) 5.267.659.1413.9516.815.218.3920.1123.1526.1
Y-o-Y Gr. Rt.-45.4%19.5%52.6%20.4%-9.5%21%9.4%15.1%12.7%
Book Value per Share (Rs.) 16.7620.5627.9835.2453.5657.8869.5791.03108.32117.99
Adjusted Net Profit 28.541.149.174.991.8126153168193218
Net Op. Cash Flow (Rs. Cr.) 40.663.479.496.294.1142167189209272
Debt to Cash Flow from Ops 0.44000000000
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Dr. Lal Pathlabs Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 21.3%14.9%13%9.3%
Adjusted EPS 19.5%9.2%12.4%12.7%
Book Value per Share 24.217.119.38.9
Share Price - - 44.8% 47.6%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 30.1440.1337.240.7334.3231.4928.6624.5922.622.34
Operating Profit Margin (%) 23.7624.920.6125.0823.5826.3726.1425.0324.2825.74
Net Profit Margin (%) 12.712.8711.6513.8514.4216.4217.3216.3716.5617.08
Debt to Equity 0.19000000000
Working Capital Days 55474243536666666252
Cash Conversion Cycle -23-20-19-17-14-15-10-12-13-15
Corporate Governance What do we look at?
Corporate Governance
Board Credentials
Promoter's holding
Transparency
Integrity
Entity Percentage Holding
Promoters 55.23%
Institutions 32.04%
Non-Institutions 12.73%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

MoneyWorks4Me analysed the past 10-year performance of Dr. Lal Pathlabs Ltd. and arrived at the following conclusion:

Past 10 year's financial track record indicates that Dr. Lal Pathlabs Ltd. is a good quality company. However, for specific investment actions please connect with your investment advisor.

Data is not available for this company.

Data is not available for this company

No data to display
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback